|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 |
| (11) | Patento numeris | 2274009 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09725345.4 |
| Europos patento paraiškos padavimo data | 2009-03-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-01-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-11-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/038509 |
| Data | 2009-03-27 |
| (87) | Numeris | WO 2009/120927 |
| Data | 2009-10-01 |
| (30) | Numeris | Data | Šalis |
| 40363 P | 2008-03-28 | US |
| (72) |
HARGREAVE, Fredrick, E., CA
VENTRESCA, Giampietro, GB
|
| (73) |
GlaxoSmithKline LLC,
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102,
US
|
| (54) | METHODS OF TREATMENT |
| METHODS OF TREATMENT |